News About: Pharm. Industry
Sales of multilevel marketers plunge last year
Sales at multilevel marketing companies in 2006 decreased sharply from a year ago, weighed down by the corruption scandal of JU Group, the country's largest network marketing company, with a market share of more than ...
Plavix ranking the top of the top 100 drugs in Korea.
Plavix, produced and distributed by Sanofi-Aventis Korea took the top position among the top 100 drugs in 2006 according to the KPMA report titled "Top 100 drugs produced in 2006" released on June 28.
Abilify, an a...
Competition will heat up in anti-obesity medicine market
Competition is about to heat up in the domestic anti-obesity medicines market, as the US-based Abbott Reductil's patent is scheduled for expiration on this July 1 and a number of its generics are lining up side by sid...
Prices of major OTC drugs raised 10% in July.
Taking effect from July the prices of major non-prescription drugs including Dongwha's Fucidin will be 10% up on average.
Madecasol (Dongkuk), an ointment for burn wound treatment, raised its price by 10% effectiv...
Lilly, market launching of Strattera for ADHD treatment.
Lilly Korea announced market launching of Strattera (atomoxetine), an ADHD therapeutic drug, having 24 hour sustained activity by once a day administration.
Strattera (atomoxetine), a new non-stimulant drug to tre...
Top 100 companies made 87% of total pharmaceutical production.
The total pharmaceutical production in 2006 reported 12,362,031,380 thousand, of which the top 100 companies produced 87.35% at 10,798,121,600 thousand, the top 20 companies 44.09% at 5,450,079,400 thousand and the t...
Chong Kun Dang, Hanall to benefit from U.S. court ruling over Plavix
Some domestic drug manufacturers, such as Chong Kun Dang Pharmaceutical and Hanall Pharm, who are using a different salt from Sanifi-Aventis's Plavix (clopidogrel bisulfate) will strengthen their presence in local ant...
Daewoong to launch anti-obesity agent 'NBU'
Daewoong Pharm will begin its anti-obesity agent that is called NBU (sibutramine), a prosumer based trade name, from next month.
Prosumer is a portmanteau formed by contracting either the word professional with the...
Ethical sales grow 12% in May
The domestic ethical market for outpatients in May grew 12.3 percent to 593.3 billion won, compared to the same period last year, according to pharmaceutical business sources.
Korea major ten drug makers recorded 2...
MSD rotavirus vaccine approved to launch market
The KFDA approved Rotateq for the prevention of infant's viral infections in the gastrointestinal tracts by G1, G2, G3, G4, G9PIA (8) types of rotavirus.
The market distribution of Rotateq and customers servic...
